Genetic changes in the HECT ubiquitin ligase HUWE1 are associated with intellectual disability, but it remains unknown whether HUWE1 functions in post-mitotic neurons to affect circuit function. Using genetics, pharmacology, and electrophysiology, we show that EEL-1, the HUWE1 ortholog in C. elegans, preferentially regulates GABAergic presynaptic transmission. Decreasing or increasing EEL-1 function alters GABAergic transmission and the excitatory/inhibitory (E/I) balance in the worm motor circuit, which leads to impaired locomotion and increased sensitivity to electroshock. Furthermore, multiple mutations associated with intellectual disability impair EEL-1 function. Although synaptic transmission defects did not result from abnormal synapse formation, sensitizing genetic backgrounds revealed that EEL-1 functions in the same pathway as the RING family ubiquitin ligase RPM-1 to regulate synapse formation and axon termination. These findings from a simple model circuit provide insight into the molecular mechanisms required to obtain E/I balance and could have implications for the link between HUWE1 and intellectual disability.
In Brief
Genetic changes in the HECT ubiquitin ligase EEL-1/HUWE1 are associated with intellectual disability. Using C. elegans, Opperman et al. show that EEL-1/HUWE1 is required for GABAergic presynaptic transmission and excitatory/inhibitory (E/I) transmission balance. These findings have potentially important implications for the link between HUWE1 and intellectual disability.
INTRODUCTION
GABA (g-aminobutyric acid) is the principal inhibitory neurotransmitter in the mammalian brain and in the simple motor circuit of the nematode C. elegans. In both cases, inhibition by GABA is necessary to achieve a balance of excitatory and inhibitory transmission that is required for proper circuit function and behavior (Gatto and Broadie, 2010; Zhen and Samuel, 2015) . Imbalances in the excitatory/inhibitory (E/I) ratio is a central feature of many neurodevelopmental disorders, including autism, epilepsy, and intellectual disability (Gatto and Broadie, 2010; Rubenstein and Merzenich, 2003) .
The motor circuit of C. elegans relies on a precise balance of cholinergic excitation and GABAergic inhibition of body wall muscles to generate locomotion (Zhen and Samuel, 2015) . This model circuit has been tremendously useful for understanding the molecular mechanisms of presynaptic transmission (Barclay et al., 2012) . Recent studies have begun to explore the molecular mechanisms that regulate E/I balance in the worm motor circuit, which remain poorly understood (Cherra and Jin, 2016; Jospin et al., 2009; Kowalski et al., 2014; Stawicki et al., 2011; Vashlishan et al., 2008) . Over the past decade, this simple circuit has also emerged as a valuable tool for understanding the molecular and cellular mechanisms that affect neurodevelopmental disorders such as epilepsy and autism (Bessa et al., 2013) .
The HECT, UBA and WWE domain-containing protein 1 (HUWE1) is a homologous to E6AP c-terminus domain (HECT) family ubiquitin ligase with growing genetic links to intellectual disability. Increased copies of HUWE1 are associated with non-syndromic intellectual disability (Friez et al., 2016; Froyen et al., 2008 Froyen et al., , 2012 Madrigal et al., 2007) . Missense mutations in HUWE1 occur in multiple families with intellectual disability, including families with Juberg-Marsidi-Brooks syndrome (Friez et al., 2016; Froyen et al., 2008; Isrie et al., 2013) . This suggests that both increased and decreased HUWE1 function could be associated with intellectual disability, but evidence from an in vivo model system supporting or refuting this possibility remains absent.
Huwe1 functions in early development of the nervous system by regulating neural progenitor proliferation and differentiation (Forget et al., 2014; Zhao et al., 2008) . This function of Huwe1 is critical for laminar patterning of the cortex (Zhao et al., 2009 ). In the hippocampus, Huwe1 regulates neural stem cell quiescence (Urbá n et al., 2016) . Huwe1 also ubiquitinates and degrades Mitofusin, an important regulator of mitochondrial fusion (Leboucher et al., 2012) . In C. elegans, there is a single ortholog of HUWE1 called enhancer of EFL mutant phenotype 1 (EEL-1), which has primarily been studied in embryonic development (Page et al., 2007) . EEL-1 was recently shown to affect neuroblast migration, indicating that EEL-1 and Huwe1 are conserved regulators of neural progenitors (de Groot et al., 2014) .
Whether Huwe1 or EEL-1 have roles in post-mitotic neurons, affect synaptic transmission, or impact circuit function remains largely unexplored. Given mounting genetic evidence linking HUWE1 and intellectual disability, addressing these issues using model circuits has become increasingly necessary. Experiments in worms and flies hinted at expanded functions for EEL-1 and HUWE1 in the nervous system beyond early development. A C. elegans RNAi screen with the drug aldicarb, a pharmacological inhibitor of acetylcholinesterase, implicated EEL-1 in neuronal function at the neuromuscular junction (NMJ) (Sieburth et al., 2005) . In flies, ectopic expression of human HUWE1 results in aberrant axon branch formation in the dorsal cluster neurons (Vandewalle et al., 2013) .
We have explored the function of EEL-1 using the motor circuit of C. elegans. Our results indicate that EEL-1 is expressed broadly in the nervous system, including both the excitatory cholinergic and inhibitory GABAergic motor neurons, but preferentially affects presynaptic GABAergic transmission. Reduced GABAergic transmission in eel-1 mutants impairs locomotion and increases sensitivity to electroshock-induced paralysis, which can be reversed by the anticonvulsant drug retigabine. Furthermore, decreasing or increasing EEL-1 function causes opposing effects on GABAergic transmission. These observations suggest that EEL-1 is required to obtain E/I balance in a simple, well defined model circuit. Although defects in GABAergic transmission are not due to failed synapse formation, analysis of different types of neurons with sensitizing genetic backgrounds uncovered a less prominent EEL-1 function in synapse formation and axon termination. Our results indicate that eel-1 functions in the same genetic pathway as the regulator of presynaptic morphology 1 (rpm-1), an intracellular signaling hub and RING family ubiquitin ligase that regulates synapse and axon development . These findings expand our understanding of how EEL-1 functions in the nervous system and indicate that EEL-1 regulates GABAergic presynaptic transmission and is required for E/I balance in a simple model circuit.
RESULTS

Both Decreased and Increased EEL-1 Activity Alter Motor Neuron Function
The C. elegans motor circuit uses acetylcholine (ACh) as an excitatory neurotransmitter. The cholinergic motor neurons innervate the body wall muscles and stimulate muscle contraction. GABA is the inhibitory transmitter in the worm motor circuit, and GABAergic motor neurons stimulate muscle relaxation. Locomotion is thought to arise from cholinergically mediated contraction and GABA-induced relaxation on opposing sides of the animal (Zhen and Samuel, 2015) The acetylcholinesterase inhibitor aldicarb is a classic pharmacological assay of motor neuron function (Barclay et al., 2012) . Application of aldicarb to an animal reduces ACh hydrolysis in the synaptic cleft of the NMJ. This leads to ACh accumulation, overstimulation of ACh receptors on muscles, and eventual paralysis. Previous studies identified RNAi targets and mutants that are resistant to inhibitors of cholinesterase (Ric) (Miller et al., 1996; Sieburth et al., 2005) and mutants that are hypersensitive to inhibitors of cholinesterase (Hic) (Loria et al., 2004; Vashlishan et al., 2008) . The Ric phenotype is often caused by a reduction in ACh exocytosis leading to delayed paralysis. In contrast, two types of impairments can result in Hic phenotypes: enhanced ACh release from cholinergic motor neurons, resulting in more rapid paralysis, and reduced inhibitory GABAergic transmission to muscles, which causes E/I imbalance and more rapid paralysis.
The Kaplan lab previously showed that feeding animals bacteria expressing eel-1 RNAi results in a moderate Ric phenotype (Sieburth et al., 2005) . Using the same RNAi-sensitizing genetic background, eri-1; lin-15B, we observed similar results ( Figures  1B and 1C) . In contrast, eel-1 RNAi resulted in the opposing phenotype, hypersensitivity to aldicarb, when a higher-sensitivity RNAi strain, uIs57; lin-15B, was used (Figures 1D and 1E; Calixto et al., 2010) .
To address these contradictory findings with RNAi, we tested two eel-1 null mutants, ok1575 and zu462 ( Figure 1A ). Both eel-1 mutants were hypersensitive to aldicarb (Figures 1F and 1G) . This phenotype was rescued by transgenic expression of EEL-1 using a native eel-1 promoter or pan-neuronal promoter but not with expression of the negative control GFP ( Figures  2A and 2B) . Thus, expression of EEL-1 in neurons is sufficient to rescue hypersensitivity to aldicarb caused by eel-1 (lf).
Because increased cholinergic or reduced GABAergic function results in a Hic phenotype, we tested cell-specific promoters for rescue. Expression of EEL-1 with a GABAergic motor neuron promoter rescued aldicarb hypersensitivity in eel-1 mutants (Figures 2C and 2D) . Rescue did not occur with promoters for the cholinergic motor neurons or muscles ( Figures 2C and 2D ).
We noted in rescue experiments that a subset of transgenic arrays, which can have variable levels of expression, showed resistance to aldicarb ( Figure S1 ). Therefore, we tested how aldicarb responses are affected by transgenic overexpression of EEL-1 in wild-type animals. As shown in Figures 2E and 2F , overexpression of EEL-1 using a pan-neuronal driver caused mild resistance to aldicarb (Figures 2E and 2F) . Overexpression with a GABAergic promoter also resulted in aldicarb resistance. In contrast, overexpression of negative control proteins (GFP or mCherry) had no effect.
These results show that loss and gain of EEL-1 function in GABAergic motor neurons produces opposing aldicarb effects. Thus, EEL-1 is both necessary and sufficient for the aldicarb response. These results are consistent with EEL-1 being required to achieve E/I balance in the motor circuit.
EEL-1 Regulates Presynaptic Transmission in GABAergic Motor Neurons
To explore the physiological mechanism underpinning EEL-1 effects on the aldicarb response, we turned to electrophysiology. To isolate GABAergic function, we recorded neuromuscular transmission by patch-clamping muscle cells in the presence of tubocurarine, an Ach receptor blocker (Richmond and Jorgensen, 1999) . eel-1 mutants had reduced frequency of GABAergic miniature inhibitory postsynaptic currents (mIPSCs) (Figures 3A and 3B) . mIPSC amplitude was mildly reduced in eel-1 mutants ( Figures 3A and 3B ). mIPSC frequency defects were rescued by an integrated transgene, bggIs16, that uses the native promoter to express EEL-1 (Figures 3C and 3D ). Defects in mIPSC amplitude trended toward rescue but were not significant (Figures 3C and 3D) . These results indicate that EEL-1 is required for presynaptic GABAergic transmission but do not rule out the possibility of a modest effect on postsynaptic function.
To assess cholinergic transmission, analysis was done in the absence of the GABA receptor (UNC-49) to ensure that only excitatory cholinergic transmission was recorded. unc-49; eel-1 mutants had no difference in cholinergic miniature excitatory postsynaptic current (mEPSC) frequency or amplitude compared with unc-49 single mutants ( Figures 3E and 3F) . Therefore, EEL-1 regulates presynaptic transmission at the GABAergic, but not the cholinergic, NMJ.
EEL-1 Is Expressed in the GABAergic Motor Neurons and Localizes to the Presynaptic Terminal
Our results with aldicarb pharmacology and electrophysiology indicate that EEL-1 regulates synaptic transmission in GABAergic motor neurons but not cholinergic motor neurons. To test whether this simply reflects eel-1 expression patterns, we generated transgenic animals that express GFP using the eel-1 promoter. Peel-1::GFP was observed in non-neuronal tissue (pharynx, intestine, and vulva; Figures S2A-S2C ) and was strongly expressed in neurons, including numerous neurons in the head ( Figure 4A ), motor neurons ( Figures 4B and 4C ), mechanosensory neurons ( Figures 4D and 4E ), HSN neurons (Figure S2D) , and tail neurons ( Figure S2E ). GFP was detected in cholinergic ( Figure 4B ) and GABAergic motor neurons (Figure 4C) . No expression was observed in muscle (data not shown). These results support our finding that EEL-1 regulates GABAergic transmission. Further, expression of eel-1 in GABAergic and cholinergic motor neurons is consistent with EEL-1 being required to maintain E/I balance in the motor circuit. Broad eel-1 expression in the nervous system leaves open the possibility that EEL-1 could regulate synaptic transmission in other types of neurons.
Next we analyzed the localization of EEL-1 in GABAergic motor neurons. We generated transgenic animals that simultaneously carry an integrated transgene that expresses Synaptobrevin-1::GFP and an extrachromosomal array that expresses mCherry::EEL-1. SNB-1::GFP and mCherry::EEL-1 were expressed with a GABAergic promoter. EEL-1 colocalizes with SNB-1 at the GABAergic presynaptic terminal ( Figure 4F ; Figure S3) . EEL-1 was also observed in cell somata but not axon commissures ( Figure S3 ). These results are consistent with EEL-1 functioning at the presynaptic terminal to regulate GABAergic transmission but do not exclude EEL-1 function in the soma. Significance was determined using an unpaired Student's t test, and error bars represent SEM. ***p < 0.001. ns, not significant.
eel-1 Mutants Have Impaired Locomotion and Heightened Sensitivity to Electroshock
Our pharmacological and electrophysiological results showed that eel-1 mutants have impaired GABAergic motor neuron function. To test how this affects animal behavior, we analyzed locomotion. Consistent with partially impaired GABAergic transmission, eel-1 (lf) animals displayed a mild uncoordinated phenotype. We assessed locomotion quantitatively by testing reverse locomotion following harsh head touch and analyzing forward locomotion during spontaneous exploration using Multi-Worm Tracker (MWT).
Following harsh touch, eel-1 mutants reversed as frequently as wild-type animals ( Figure S4 ), but the distance they reversed was significantly reduced ( Figure 5A ). Reverse locomotion defects were rescued by transgenic EEL-1 expressed with a native eel-1 or pan-neuronal promoter ( Figure 5A ). eel-1 mutants did not show the ''shrinker'' phenotype that occurs when GABAergic transmission is fully impaired, as in unc-25 mutants (data not shown).
The forward speed of eel-1 mutants was also significantly slower than in wild-type animals ( Figure 5B ). This defect was rescued by the bggIs16 transgene that expresses EEL-1 using the native promoter ( Figure 5C ). These results show that EEL-1 is required for both forward and reverse locomotion. This is consistent with prior studies showing that GABAergic transmission regulates forward and reverse locomotion and that partially impaired GABAergic transmission results in moderate locomotion defects (Petrash et al., 2013) .
Another behavior that is sensitive to E/I balance in the worm motor circuit is electroshock-induced paralysis (Risley et al., 2016) . Electroshock involves the application of voltage to animals suspended in saline buffer and results in body convulsions and paralysis. Consistent with prior work, unc-25/GAD mutants (which lack inhibitory GABAergic transmission) displayed increased electroshock sensitivity with longer time to recovery ( Figure 5D ; Risley et al., 2016) . Recovery time was also increased in eel-1 mutants and rescued by bggIs16 ( Figure 5D ). Pretreatment of eel-1 animals with retigabine (RTG), a potassium channel agonist and anticonvulsant, rescued electroshock susceptibility ( Figure 5E ). RTG most likely activates a potassium channel(s) that alleviates hyperexcitation of muscles, which results from reduced GABAergic transmission in eel-1 mutants. These behavioral results provide further evidence that EEL-1 regulates GABAergic transmission and is needed for E/I balance.
EEL-1 and Synapse Formation
One possible explanation for reduced GABAergic presynaptic transmission could be impaired synapse formation in eel-1 (lf) mutants. To address this, we examined the formation of presynaptic terminals at NMJs made by cholinergic and GABAergic motor neurons.
The motor neuron cell bodies are on the ventral side of C. elegans and extend axons that innervate dorsal muscles (Figures 6A and 6C) . Each cholinergic motor neuron extends a single axon, and individual GABAergic axons bifurcate. Both types of motor axons form evenly distributed presynaptic connections along dorsal muscles (White et al., 1976) .
NMJ formation was evaluated using transgenes that express SNB-1::GFP in cholinergic or GABAergic motor neurons. In wild-type animals, SNB-1 forms puncta at cholinergic and GABAergic presynaptic terminals that are evenly distributed along the dorsal cord ( Figures 6A and 6C ). Cholinergic NMJs of eel-1 mutants had mild SNB-1 defects with small gaps and aggregated puncta ( Figure 6A ). Quantitation showed reduced 
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Transgenic animals expressing Peel-1::GFP were analyzed using epifluorescent microscopy. numbers of puncta in eel-1 mutants ( Figure 6B ). In contrast, GABAergic motor neurons of eel-1 animals had normal organization of SNB-1 puncta ( Figures 6C and 6D ). Because cholinergic transmission is normal in eel-1 mutants ( Figures 3E and 3F ), these mild defects in cholinergic NMJ organization do not impair synaptic transmission. Normal organization of GABAergic SNB-1 puncta suggests that defects in GABAergic transmission in eel-1 mutants are not caused by defective synapse formation or impaired axon guidance. Normal GABAergic axon guidance was confirmed for eel-1 mutants using the juIs76 transgene, which expresses soluble GFP in GABAergic neurons (data not shown). Previous studies showed that defects in active zone formation also impair SNB-1 organization in motor neurons, further suggesting that GABAergic synapse formation is largely normal in eel-1 mutants (Zhen and Jin, 1999) .
Disorganized cholinergic presynaptic terminals in eel-1 mutants are reminiscent of defects that occur with loss of function in rpm-1, an intracellular signaling protein that regulates synapse formation Zhen et al., 2000) . Therefore, we tested the genetic relationship between eel-1 and rpm-1. Consistent with prior studies, cholinergic motor neurons in rpm-1 mutants had aggregated SNB-1 puncta and gaps lacking puncta ( Figure 6A ; Nakata et al., 2005) . Quantitation showed that rpm-1 mutants have a more severe phenotype than eel-1 mutants, which is not increased in rpm-1; eel-1 double mutants (Figures 6A and 6B) . These results suggest that eel-1 and rpm-1 function in the same genetic pathway to regulate presynaptic organization of cholinergic NMJs.
Because EEL-1 affects cholinergic synapse formation and functions in the same pathway as RPM-1, we examined GABAergic synapse formation more thoroughly using a sensitizing genetic background. Previous studies showed that FSN-1 mediates a portion of RPM-1 function, and fsn-1 (lf) mutants have milder synapse formation defects than rpm-1 (lf) mutants (Figures 6C and 6D ; Grill et al., 2007; Liao et al., 2004) . As a result, fsn-1 (lf) can act as a sensitizing background to reveal enhancer effects on GABAergic synapse formation. We observed that fsn-1; eel-1 double mutants had more severe defects in SNB-1 organization than fsn-1 single mutants ( Figure 6D ). These results show that fsn-1 and eel-1 function in parallel genetic pathways to regulate GABAergic synapse formation.
Next, we tested rpm-1; eel-1 double mutants for defects in GABAergic presynaptic organization. Double mutants did not have increased severity of defects compared with rpm-1 single mutants ( Figures 6C and 6D) . Thus, eel-1 and rpm-1 function in the same genetic pathway to regulate GABAergic presynaptic organization. These results suggest that EEL-1 regulates cholinergic and GABAergic synapse formation by functioning in the RPM-1 pathway and in parallel to FSN-1.
EEL-1 Regulates Axon Termination and Axon Branch Formation
Aside from its role in synapse formation, RPM-1 is also an important regulator of axon termination (Schaefer et al., 2000) . Given that eel-1 and rpm-1 function in the same pathway to regulate synapse formation, we tested whether EEL-1 regulates axon termination.
Axon termination can be rapidly evaluated in the cholinergic SAB neurons that innervate head muscles using jsIs42, a transgene with cell-specific expression of SNB-1::GFP ( Figure S5A ). In wild-type animals, SNB-1 forms puncta at presynaptic terminals along SAB axons and at axon termination sites ( Figure S5A ). Axon termination defects occurred at moderate frequency in eel-1 mutants ( Figures S5A and S5B ). Small ectopic axon branches, often referred to as sprouts, were also observed in eel-1 mutants ( Figures S5A and S5B) . In some instances, axon termination and ectopic branch defects occurred in the same SAB axon ( Figure S5A ).
Consistent with prior work (Schaefer et al., 2000) , rpm-1 (lf) mutants displayed axon termination and ectopic axon branch defects that were similar to, but more frequent than, eel-1 mutants ( Figures S5A and S5B ). The frequency of termination and branch defects did not increase in rpm-1; eel-1 double mutants ( Figure S5B ). Similar results were observed for the anterior lateral microtubule (ALM) and posterior lateral microtubule (PLM) mechanosensory neurons ( Figure S6 ), which is consistent with eel-1 expression in these cells ( Figures 4D and 4E ). These results using two different types of neurons indicate that eel-1 and rpm-1 function in the same genetic pathway to promote axon termination and inhibit ectopic axon branching.
Next we wanted to test whether eel-1 functions cell-autonomously in SAB neurons to regulate axon development. As shown in Figure S5C , transgenic expression of EEL-1 using an SAB promoter significantly rescued ectopic axon branch defects and axon termination defects. In contrast, rescue did not occur with the negative control mCherry ( Figure S5C ). Thus, eel-1 functions cell-autonomously in SAB neurons to regulate axon termination and branch formation.
In mammals, Huwe1 ubiquitinates and inhibits N-Myc to regulate neuronal progenitor proliferation (Zhao et al., 2008 (Zhao et al., , 2009 ). To test whether EEL-1 regulates axon termination through a similar mechanism, we generated double mutants of eel-1 with the single worm homolog for the Myc and Mondo transcription factors called Myc/Mondo-like 1 (MML-1). Because MML-1 functions in a complex with MXL-2, the ortholog of mammalian Mxl, we also tested eel-1; mxl-2 double mutants. Our analysis relied on previously described null alleles of mml-1 and mxl-2. Axon termination defects and ectopic branch defects in eel-1 mutants were not suppressed in eel-1; mml-1 or eel-1; mxl-2 double mutants ( Figure S5D ). Because suppression would be expected if MML-1/Myc were ubiquitinated and inhibited by EEL-1, these results suggest that EEL-1 is unlikely to regulate axon development via this mechanism.
Mutations Associated with Intellectual Disability Result in Loss of eel-1 Function At present, seven different missense mutations in HUWE1 are associated with intellectual disability, and several mutations affect residues conserved in C. elegans EEL-1 (Friez et al., 2016; Froyen et al., 2008) . Two of these mutations are shown in Figure 1A . The functional consequences of these mutations remain unknown. We tested whether EEL-1 containing disorder-associated mutations can rescue defects caused by eel-1 (lf). Unlike wild-type EEL-1, transgenic EEL-1 R2991H (which corresponds to HUWE1 R2981H) failed to rescue axon termination and axon branch defects in eel-1 mutants ( Figure S5C ). This suggests that EEL-1 R2991H is a loss-of-function mutation.
It is possible that disorder-associated mutations might impair EEL-1 in some contexts but not others. Therefore, we tested whether transgenic EEL-1 containing disorder-associated mutations can rescue the aldicarb hypersensitivity of eel-1 mutants. Although transgenic expression of wild-type EEL-1 robustly rescued aldicarb hypersensitivity, rescue was not observed with EEL-1-containing, disorder-associated mutations R2991H (which corresponds to HUWE1 R2981H) or R3990C (which corresponds to HUWE1 R4187C) (Figure 7) . Thus, the results from two different in vivo assays indicate that mutations in HUWE1 associated with intellectual disability result in loss of eel-1 function.
DISCUSSION
EEL-1 is a HECT family ubiquitin ligase orthologous to mammalian HUWE1. Copy number increases and missense mutations in HUWE1 are associated with intellectual disability. Previous work showed that Huwe1 regulates neurogenesis and migration of neural progenitors.
Our findings with genetic, pharmacological, and electrophysiological approaches now indicate that EEL-1 regulates presynaptic transmission in GABAergic motor neurons. Furthermore, our results show that EEL-1 is required to obtain E/I balance in the worm motor circuit. eel-1 mutants have defective locomotion and increased sensitivity to electroshock, consistent with impaired GABAergic transmission and E/I imbalance. We also observed that mutations in HUWE1 associated with intellectual disability result in loss of EEL-1 function in the context of GABAergic transmission. These findings expand our understanding of the molecular mechanisms required to establish E/I balance in a simple model circuit and could have important implications for the link between HUWE1 and intellectual disability. 
EEL-1 Regulates Inhibitory, GABAergic Presynaptic Transmission
We used the acetylcholinesterase inhibitor aldicarb to pharmacologically assess motor circuit function in eel-1 mutants. eel-1 (lf) mutants are hypersensitive to aldicarb, and transgenic animals overexpressing EEL-1 display the opposing phenotype-aldicarb resistance (Figures 1 and 2) . Thus, decreasing or increasing EEL-1 activity alters motor circuit function. Transgenic rescue and overexpression experiments show that EEL-1 functions cell-autonomously in GABAergic motor neurons to affect aldicarb sensitivity. Although our results suggest that the aldicarb hypersensitivity of eel-1 (lf) mutants is unlikely to stem from defects in synapse or axon development of GABAergic motor neurons, a more thorough analysis of GABAergic NMJs will be needed to entirely rule this out. Nonetheless, our results indicate that reduced GABAergic transmission in eel-1 mutants leads to E/I imbalance in the motor circuit and aldicarb hypersensitivity.
We confirmed this interpretation of aldicarb results using electrophysiology. eel-1 (lf) mutants have a reduced frequency of GABAergic mIPSCs ( Figure 3A ). The amplitude of GABAergic mIPSCs was also mildly but significantly reduced in eel-1 mutants. These results indicate that EEL-1 predominantly affects presynaptic GABAergic transmission. In contrast, both the frequency and amplitude of cholinergic mEPSCs are unchanged in eel-1 mutants, indicating that cholinergic transmission is unaffected by eel-1 (lf). These pharmacological and electrophysiological data allow us to conclude that reduced inhibitory GABAergic input to muscles in eel-1 mutants leads to a net increase in E/I ratio from the motor circuit. Impaired GABAergic transmission in eel-1 (lf) mutants is likely to explain why these animals have behavioral abnormalities, including reduced locomotion and increased electroshock sensitivity.
Although EEL-1 functions in GABAergic motor neurons to regulate aldicarb hypersensitivity and presynaptic transmission, EEL-1 does not function exclusively in these neurons. EEL-1 is expressed in both GABAergic and cholinergic motor neurons (Figure 4 ). This suggests that EEL-1 is required to obtain motor circuit E/I balance rather than being required exclusively for GABAergic transmission. Broad nervous system expression also suggests that EEL-1 might regulate neurotransmission in other neurons.
EEL-1 colocalizes with SNB-1, suggesting that EEL-1 could regulate GABAergic transmission locally ( Figure 4F ). Consistent with this, Huwe1 associates with the synaptic proteasome in cultured neurons (Tai et al., 2010) . Further evidence that EEL-1 ubiquitin ligase activity might regulate synaptic transmission stems from two observations: both eel-1 deletion alleles result in loss of the HECT ubiquitin ligase domain ( Figure 1A) , and a disorder-associated point mutation in the HECT domain, R3990C, impairs EEL-1 function (Figure 7) . However, ubiquitin ligase-independent mechanisms cannot be ruled out because a mutation outside of the HECT domain (R2991H) also impairs EEL-1 function.
At present, little is known about ubiquitin ligases that regulate presynaptic transmission in vivo. In mice, Scrapper degrades RAB3 interacting molecule (RIM) to inhibit presynaptic transmission (Yao et al., 2007) . Parkin and the anaphase promoting complex (APC) regulate presynaptic transmission at the fly and worm NMJ (Kowalski et al., 2014; van Roessel et al., 2004; Vincent et al., 2012) . Notably, Scrapper, Parkin, and the APC are RING family ubiquitin ligases. Our findings now show that a HECT ubiquitin ligase, EEL-1, preferentially regulates GABAergic transmission.
EEL-1 and Synaptic Transmission: Implications for HUWE1 and Intellectual Disability The worm motor circuit requires E/I balance for proper function, which makes this model circuit valuable for studying the molecular and cellular mechanisms of neurodevelopmental disorders (Bessa et al., 2013) . Our results indicate that EEL-1 is required for GABAergic presynaptic transmission and E/I balance in the motor circuit. Like the worm motor circuit, GABA is inhibitory in the mammalian brain. The obvious caveats of our simple system aside, if HUWE1 is a conserved regulator of GABAergic transmission, then increased or reduced HUWE1 function might affect E/I balance in the brain. This could have important implications for HUWE1 and intellectual disability because E/I imbalances occur in many neurodevelopmental disorders (Gatto and Broadie, 2010; Rubenstein and Merzenich, 2003) .
Increased copies of HUWE1 are associated with intellectual disability, and missense mutations in HUWE1 are associated with intellectual disability as part of Juberg-Marsidi-Brooks syndrome. An explanation for how differing HUWE1 genetic changes lead to intellectual disability remains absent. Using in vivo neuronal assays, we have shown that two mutations associated with intellectual disability impair eel-1 function (Figure 7) . The mutated residues are identical in EEL-1 and HUWE1, suggesting that they are likely to result in loss of HUWE1 function. Nonetheless, these mutations are presumably hypomorphic in some contexts (for example, early neurogenesis) because Huwe1 knockout is lethal (Zhao et al., 2009 ). Overexpression of EEL-1 in GABAergic motor neurons results in altered motor circuit function and resistance to aldicarb. Thus, copy number increases in HUWE1 could potentially affect GABAergic transmission. If increased and reduced HUWE1 function are associated with intellectual disability, HUWE1 would join SHANK3 and MECP2 as genes with both gain-and loss-offunction changes associated with intellectual disability (Zoghbi and Bear, 2012) .
Our previous work showed that impaired GABAergic transmission caused by unc-25/GAD (lf) results in E/I imbalance in the motor circuit and increased sensitivity to electroshock (Risley et al., 2016) . eel-1 (lf) mutants also have increased electroshock sensitivity, consistent with reduced GABAergic transmission ( Figure 5D ). This defect is suppressed by the anticonvulsant RTG, an agonist for KCNQ2/3 voltage-gated potassium channels in mice and flies (Barrese et al., 2010) . Although it is unclear how RTG rescues eel-1 mutants, one possibility is that RTG relieves hyperexcitation in eel-1 mutants by stimulating potassium channels. Given that electroshock is often used to study seizure in different systems and keeping in mind the limitations of our worm electroshock assay, it is noteworthy that subsets of individuals with genetic changes in HUWE1 experience seizures (Froyen et al., 2008 (Froyen et al., , 2012 .
eel-1 and rpm-1 Function in the Same Pathway to Regulate Neuronal Development EEL-1 and Huwe1 are single-subunit ubiquitin ligases of the HECT family. The HECT family includes Ube3a, Nedd4, and Smurf, which have important roles in neuronal development (Ambrozkiewicz and Kawabe, 2015; Yamada et al., 2013) . Previous work showed that EEL-1 and Huwe1 regulate neural progenitor proliferation and migration (de Groot et al., 2014; Forget et al., 2014; Zhao et al., 2009) . We have explored the role of EEL-1 in later developmental events, such as synapse formation and axon termination.
Axon termination defects in SAB neurons and mechanosensory neurons were the most prevalent developmental defects we observed in eel-1 (lf) mutants (Figures S5 and S6) . Small ectopic axon branches, referred to as sprouts, were also observed in the SAB neurons of eel-1 (lf) mutants. Previous work showed that transgenic overexpression of Huwe1 results in ectopic axon branching in flies (Vandewalle et al., 2013) . Our findings and this prior work indicate that decreasing or increasing EEL-1/Huwe1 function can affect axon termination and branching.
We examined presynaptic organization in cholinergic and GABAergic motor neurons of eel-1 (lf) mutants. As mentioned earlier, GABAergic presynaptic organization was normal in eel-1 mutants ( Figures 6C and 6D) . We observed mild defects in cholinergic motor neurons, which did not impair cholinergic transmission. Thus, EEL-1 figures more prominently in GABAergic transmission and has a minor role in presynaptic organization in cholinergic motor neurons. Although our results indicate that motor neuron synapse formation is largely normal in eel-1 mutants, they do not rule out the possibility subtle defects in presynaptic terminals could affect GABAergic transmission.
Axon termination defects and cholinergic presynaptic organization defects in eel-1 mutants were similar, but milder, than what occurs in rpm-1 mutants. Therefore, we explored the genetic relationship between eel-1 and rpm-1 in synapse and axon development. Previous work established RPM-1 and orthologous Pam/Highwire/RPM-1 (PHR) proteins as regulators of synapse and axon development . RPM-1 is an intracellular signaling hub that regulates several downstream pathways (Baker et al., 2014; Grill et al., 2007 Grill et al., , 2012 Nakata et al., 2005; Tulgren et al., 2014) . Our analysis indicates that fsn-1, an F box protein that mediates a portion of RPM-1 signaling, functions in a parallel pathway with eel-1 to regulate GABAergic synapse formation and axon termination ( Figures  6C and 6D ; Figure S6 ). Like other fsn-1 enhancers, eel-1 functions in the same genetic pathway as rpm-1. These genetic results are consistent with EEL-1 and RPM-1 localizing to GABAergic presynaptic terminals ( Figure 4F ; Zhen et al., 2000) .
Work using non-neuronal cells showed that the RPM-1 ortholog Pam/MYCBP2 can function in a ubiquitin ligase complex with Huwe1 (Yin et al., 2010) . Our genetic results suggest that RPM-1 could function in one complex with EEL-1 and in a different complex with FSN-1. Prior evidence indicates that RPM-1 can function through two mechanisms, RPM-1/FSN-1 ubiquitin ligase activity and RPM-1 recruitment of the PPM-2 phosphatase, to restrict the DLK-1 mitogen activated protein kinase kinase kinase (MAP3K) (Baker et al., 2014; Nakata et al., 2005) . Thus, RPM-1 might utilize FSN-1 and EEL-1 as different mechanisms to regulate DLK-1 or other molecules in the DLK-1/PMK-3 p38 mitogen-activated protein kinase (MAPK) pathway.
Another potential link between EEL-1 and RPM-1 is b-catenin signaling. EEL-1 regulates neuroblast migration by inhibiting the Wnt effector protein Dishevelled, which regulates b-catenin (de Groot et al., 2014) . RPM-1 regulates axon termination and synapse formation by binding to the Nesprin ANC-1 and regulating b-catenin signaling . Therefore, RPM-1 and EEL-1 might function in the same genetic pathway because they both affect b-catenin signaling.
Genetic and molecular links between RPM-1 signaling and neurodevelopmental disorders have begun to emerge. For example, Pam regulates the tuberous sclerosis complex (TSC), which is linked to tuberous sclerosis and autism (Han et al., 2012; Murthy et al., 2004) . Microduplications and microdeletions that include Fbxo45, the ortholog of FSN-1, are associated with neurodevelopmental disorders . Our findings now provide in vivo genetic evidence from a model system linking the RPM-1 signaling network to eel-1, a gene associated with intellectual disability.
Conclusions
Our results with a simple model circuit indicate that EEL-1 regulates presynaptic GABAergic transmission. This EEL-1 function is required for proper locomotion, affects sensitivity to electroshock, and provides important insight into the molecular mechanisms required to establish E/I balance. Our findings could also have important implications for the link between EEL-1 and intellectual disability, which is heightened by our observation that mutations associated with intellectual disability lead to loss of EEL-1 function in neurons in vivo. Although we have learned much about the electrophysiological and cellular mechanisms by which EEL-1 regulates GABAergic transmission, an intriguing and challenging future goal will be understanding the molecular mechanisms by which EEL-1 regulates GABAergic transmission.
EXPERIMENTAL PROCEDURES
Further details and expanded methods can be found in the Supplemental Experimental Procedures.
Strains and Genetics
The C. elegans N2 isolate was propagated and maintained using standard procedures. The alleles used included eel-1 (zu462), eel-1 (ok1575), rpm-1 (ju44), rpm-1 (ok364), fsn-1 (gk429), goa-1 (n363), ric-3 (md158), unc-4 (e120), mml-1 (ok849), mxl-2 (tm1516), and unc-49 (e407 We sequenced to confirm the nature of the lesions in ok1575 and zu462. ok1575 is a 1,637-bp deletion that removes intronic and exonic sequences. Failed splicing in ok1575 is likely to create a premature stop, resulting in loss of more than 50% of the EEL-1 sequence, including the HECT ubiquitin ligase domain ( Figure 1A ). zu462 is an inverted duplication that results in a large deletion and insertion of 5,884 bp. zu462 disrupts the eel-1 reading frame, leads to 36 amino acids of non-sense sequence and a stop codon, and results in a truncated protein lacking a HECT domain ( Figure 1A ).
Transgenics
Transgenic animals were generated using standard microinjection procedures. Extrachromosomal transgenic arrays were constructed by injecting animals with the plasmid or PCR product of interest, P ttx-3 RFP (50 ng/mL) or P myo-2 mCherry (1 ng/mL) as coinjection marker, and pBluescript (25-90 ng/mL) to normalize injections to 100 ng/mL total DNA. For eel-1 promoter expression, shown in Figure 4 , pha-1(e2123) was used as a temperature-sensitive positive selection marker. The precise composition of injection mixtures and genotypes of animals used in this study are annotated in Table S1 . The transgenic line bggIs16 [P eel-1 EEL-1] was generated by UV/4,5 0 ,8-trimethylpsoralen (TMP) integration of bggEx117. bggIs16 was outcrossed seven times to N2 worms and mated to eel-1 (zu462) for rescue experiments. bggEx117 was generated by injecting P eel-1 EEL-1 (pBG-GY550, 75 ng/mL), P myo-2 mCherry (1 ng/mL), and pBluescript (25 ng/mL). Transgenic strains used for confocal imaging, shown in Figure 4F and Figure S3 , were generated by injecting transgenic animals carrying juIs1 [P unc-25 SNB-1::GFP] with the following plasmid mixture: pBG-GY656 (P unc-25 mCherry::EEL-1, 40 ng/mL), pBG-GY322 (P myo-2 mCherry, 1 ng/mL), and pBlueScript (60 ng/mL). Two independent lines were isolated and analyzed: bggEx125; juIs1 and bggEx126; juIs1.
Aldicarb Assay
Nematode growth media (NGM) plates with aldicarb (Aldicarb-Pestanal, Sigma) and a spot of OP-50 E. coli were warmed to room temperature for 3 hr prior to experimentation. Animals (blinded for genotype) were individually touched on the posterior body to assess movement every 15 min. Animals were considered paralyzed when no body or head movement was detected. Initially, for analysis of eel-1 RNAi and mutants, 1 mM aldicarb was used. To more accurately separate differences in hypersensitivity for different genotypes, subsequent experiments were performed with 0.5 mM aldicarb because this lower concentration enhanced the sensitivity of aldicarb responses. Prior to the aldicarb assays, all strains were grown at 23 C.
Forward Speed during Exploratory Locomotion C. elegans locomotion was assessed as described previously (Giles et al., 2015) . Briefly, C. elegans were cultivated at 23 C, and synchronized adults were placed on NGM agar plates without E. coli and allowed to spontaneously explore for 5 min. Behavioral recordings of this exploration were taken using an adapted version of MWT. Centroid speed during periods of forward locomotion was measured during the final minute of observation. The average speed of $30 worms was measured at a time on one plate and considered a single data point; six to nine plates were tested per strain. Some mutants had a significantly smaller body length than the wild-type, which could affect absolute speed. To control for this, speed was standardized to body length. Only absolute speed is presented because similar results were observed when standardized. In-depth details regarding forward locomotion analysis with MWT analysis can be found in the Supplemental Experimental Procedures.
Electrophysiology
Electrophysiological recordings were performed as described previously (Gao and Zhen, 2011) . The intracellular solution contained K-gluconate, 115 mM; KCl, 25 mM; CaCl 2 , 0.1 mM; MgCl 2 , 5 mM; 1, 2-bis (o-aminophenoxy) ethane-N, N, N 0 , N 0 -tetraacetic acid (BAPTA), 1 mM; HEPES, 10 mM; Na 2 ATP, 5 mM; Na 2 guanosine triphosphate (GTP), 0.5 mM; cyclic AMP (cAMP), 0.5 mM; and cyclic GMP (cGMP), 0.5 mM (pH 7.2 with potassium hydroxide [KOH], 320 mOsm). The extracellular solution contained NaCl, 150 mM; KCl, 5 mM; CaCl 2 , 5 mM; MgCl 2 , 1 mM; glucose, 10 mM; sucrose, 5 mM; and HEPES, 15 mM (pH 7.3 with NaOH, 330 mOsm). GABAergic mIPSCs were recorded in the presence of 0.5 mM d-tubocurarine in the extracellular solution to block cholinergic receptors while holding the membrane at À10 mV so GABAergic mIPSCs appeared as outward currents (Maro et al., 2015) . Cholinergic mEPSCs were recorded in the background of unc-49 (e407), a loss-of-function mutation in the GABA receptor, while holding the membrane at À60 mV. All experiments were performed at room temperature (20 C-22 C).
Electroshock Assay
The electric shock procedure was performed as described previously (Risley et al., 2016) . 1-day-old adult C. elegans (approximately 10 animals/electroshock assay) were incubated for 30 min with or without retigabine and subjected to electric shock for three seconds (204 Hz, 47 V). Videos were manually scored to quantify the time needed to recover from electroshock. The Supplemental Experimental Procedures contain further details.
Analysis of Developmental Phenotypes
Young adult animals were anesthetized using 2% (v/v) 1-phenoxy-2-propanol in M9 buffer. Synchronized young adults were analyzed for cholinergic motor neurons (nuIs152) and GABAergic motor neurons (juIs1), whereas non-synchronized young adult animals were analyzed for SAB neurons (jsIs42) and mechanosensory neurons (muIs32). Analysis with nuIs152, juIs1, and jsIs42 was done on worms grown at 25 C, and analysis with muIs32 was done on worms grown at 23 C. jsIs42 animals were visualized using 633 magnification, and muIs32, juIs1 and nuIs152 animals were visualized using 403 magnification oil immersion and an epifluorescence microscope (Leica CRF 5000). Images of anesthetized animals were taken using a charge-coupled device (CCD) camera (Leica DFC345 FX). Image analysis was performed using Leica Application Suite for Advanced Fluorescence (LAS-AF) software. For nuIs152 and juIs1, images from the dorsal cord were measured using LAS-AF software, and the number of SNB-1::GFP puncta were manually scored using Adobe Photoshop.
Confocal Microscopy
Animals were paralyzed in 5 mM levamisole. Confocal imaging was done using a Leica TCS SP8 MP confocal microscope system in resonant mode with a 403 water immersion lens (HC PL APO 403/1.10 CS2). Images were acquired using the Leica acquisition software with a 2-103 zoom factor. ImageJ (version 1.50d) was used to process the images. For presentation of confocal stacks, either a single slice was used, or the maximum intensity projection was used as noted. Further details are available in the Supplemental Experimental Procedures. 
Statistical Analysis
